Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$32.4 - $68.18 $154,029 - $324,127
4,754 New
4,754 $324,000
Q2 2020

Aug 12, 2020

SELL
$48.73 - $81.82 $3,411 - $5,727
-70 Closed
0 $0
Q1 2020

Aug 05, 2021

SELL
$41.72 - $87.2 $183,693 - $383,941
-4,403 Reduced 98.44%
70 $4,000
Q1 2020

May 12, 2020

BUY
$41.72 - $87.2 $183,568 - $383,680
4,400 Added 6027.4%
4,473 $228,000
Q4 2019

Aug 05, 2021

SELL
$45.7 - $81.86 $243,443 - $436,068
-5,327 Reduced 98.65%
73 $6,000
Q4 2019

Feb 11, 2020

BUY
$45.7 - $81.86 $243,443 - $436,068
5,327 Added 7297.26%
5,400 $429,000
Q3 2019

Aug 05, 2021

SELL
$45.35 - $57.91 $224,482 - $286,654
-4,950 Reduced 98.55%
73 $4,000
Q3 2019

Nov 13, 2019

BUY
$45.35 - $57.91 $224,391 - $286,538
4,948 Added 6597.33%
5,023 $243,000
Q2 2019

Aug 05, 2021

SELL
$52.6 - $63.29 $291,824 - $351,132
-5,548 Reduced 98.67%
75 $4,000
Q2 2019

Aug 08, 2019

BUY
$52.6 - $63.29 $29,456 - $35,442
560 Added 11.06%
5,623 $0
Q1 2019

May 15, 2019

SELL
$39.99 - $53.48 $10,437 - $13,958
-261 Reduced 4.9%
5,063 $0
Q4 2018

Feb 07, 2019

BUY
$31.54 - $46.67 $14,855 - $21,981
471 Added 9.71%
5,324 $218,000
Q2 2018

Aug 13, 2018

SELL
$38.7 - $50.15 $2.81 Million - $3.64 Million
-72,505 Reduced 93.73%
4,853 $0
Q4 2017

Feb 13, 2018

SELL
$29.7 - $45.7 $1.17 Million - $1.81 Million
-39,537 Reduced 33.82%
77,358 $3.14 Million
Q3 2017

Nov 02, 2017

BUY
$25.1 - $31.05 $2.93 Million - $3.63 Million
116,895
116,895 $3.63 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.